David Rickey, Director at CYTORI THERAPEUTICS, INC. (CYTX), bought 18,875 shares at $2.14 ($41K) on 2013-09-03, disclosed to the SEC on 2013-09-05.
Open-market purchase of $41k CYTX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.13 | 400 | $852 | 2.1% |
| 2 | $2.14 | 2,000 | $4K | 10.4% |
| 3 | $2.14 | 4,600 | $10K | 24.0% |
| 4 | $2.20 | 11,875 | $26K | 63.6% |
| Total | $2.18 avg | 18,875 | $41K | 100% |
| Filing → |
| CYTX | BUY | 2015-08-31 | $17K | — | Filing → |
| CYTX | BUY | 2015-08-28 | $23K | — | Filing → |
| CYTX | BUY | 2015-08-24 | $19K | — | Filing → |